198 related articles for article (PubMed ID: 37272752)
1. Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation.
Cui W; Huang Z; Jin SG; Johnson J; Lau KH; Hostetter G; Pfeifer GP
Cancer Res; 2023 Aug; 83(15):2480-2495. PubMed ID: 37272752
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori-infection-associated CpG island hypermethylation in the stomach and its possible association with polycomb repressive marks.
Yoo EJ; Park SY; Cho NY; Kim N; Lee HS; Kang GH
Virchows Arch; 2008 May; 452(5):515-24. PubMed ID: 18335237
[TBL] [Abstract][Full Text] [Related]
3. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
McCabe MT; Lee EK; Vertino PM
Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
[TBL] [Abstract][Full Text] [Related]
4. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.
He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y
Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314
[TBL] [Abstract][Full Text] [Related]
5. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.
Farcas AM; Blackledge NP; Sudbery I; Long HK; McGouran JF; Rose NR; Lee S; Sims D; Cerase A; Sheahan TW; Koseki H; Brockdorff N; Ponting CP; Kessler BM; Klose RJ
Elife; 2012 Dec; 1():e00205. PubMed ID: 23256043
[TBL] [Abstract][Full Text] [Related]
6. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
7. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line.
Gal-Yam EN; Egger G; Iniguez L; Holster H; Einarsson S; Zhang X; Lin JC; Liang G; Jones PA; Tanay A
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12979-84. PubMed ID: 18753622
[TBL] [Abstract][Full Text] [Related]
8. Genomic insights into cancer-associated aberrant CpG island hypermethylation.
Sproul D; Meehan RR
Brief Funct Genomics; 2013 May; 12(3):174-90. PubMed ID: 23341493
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
10. Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation.
Mohammad HP; Cai Y; McGarvey KM; Easwaran H; Van Neste L; Ohm JE; O'Hagan HM; Baylin SB
Cancer Res; 2009 Aug; 69(15):6322-30. PubMed ID: 19602592
[TBL] [Abstract][Full Text] [Related]
11. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.
Breuer RH; Snijders PJ; Sutedja GT; Sewalt RG; Otte AP; Postmus PE; Meijer CJ; Raaphorst FM; Smit EF
Lung Cancer; 2005 Jun; 48(3):299-306. PubMed ID: 15892997
[TBL] [Abstract][Full Text] [Related]
12. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation.
Kaneda A; Tsukamoto T; Takamura-Enya T; Watanabe N; Kaminishi M; Sugimura T; Tatematsu M; Ushijima T
Cancer Sci; 2004 Jan; 95(1):58-64. PubMed ID: 14720328
[TBL] [Abstract][Full Text] [Related]
13. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation: TET proteins-guardians of CpG islands?
Williams K; Christensen J; Helin K
EMBO Rep; 2011 Dec; 13(1):28-35. PubMed ID: 22157888
[TBL] [Abstract][Full Text] [Related]
15. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers.
Olaru AV; Cheng Y; Agarwal R; Yang J; David S; Abraham JM; Yu W; Kwon JH; Lazarev M; Brant SR; Marohn MR; Hutcheon DF; Harpaz N; Meltzer SJ; Mori Y
Inflamm Bowel Dis; 2012 Apr; 18(4):641-8. PubMed ID: 21830278
[TBL] [Abstract][Full Text] [Related]
16. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation.
Hahn MA; Hahn T; Lee DH; Esworthy RS; Kim BW; Riggs AD; Chu FF; Pfeifer GP
Cancer Res; 2008 Dec; 68(24):10280-9. PubMed ID: 19074896
[TBL] [Abstract][Full Text] [Related]
17. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.
Rauch T; Wang Z; Zhang X; Zhong X; Wu X; Lau SK; Kernstine KH; Riggs AD; Pfeifer GP
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5527-32. PubMed ID: 17369352
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation patterns in lung carcinomas.
Pfeifer GP; Rauch TA
Semin Cancer Biol; 2009 Jun; 19(3):181-7. PubMed ID: 19429482
[TBL] [Abstract][Full Text] [Related]
19. DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.
Skvortsova K; Masle-Farquhar E; Luu PL; Song JZ; Qu W; Zotenko E; Gould CM; Du Q; Peters TJ; Colino-Sanguino Y; Pidsley R; Nair SS; Khoury A; Smith GC; Miosge LA; Reed JH; Kench JG; Rubin MA; Horvath L; Bogdanovic O; Lim SM; Polo JM; Goodnow CC; Stirzaker C; Clark SJ
Cancer Cell; 2019 Feb; 35(2):297-314.e8. PubMed ID: 30753827
[TBL] [Abstract][Full Text] [Related]
20. Evidence that general genomic hypomethylation and focal hypermethylation are two independent molecular events of non-Hodgkin's lymphoma.
Pini JT; Franchina M; Taylor JM; Kay PH
Oncol Res; 2004; 14(7-8):399-405. PubMed ID: 15301431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
